Search

Jilin Jingkai Hangyang Gases Co., Ltd. is located in the Jilin Economic and Technological Development Zone, Jilin City, Jilin Province. It is a mixed-ownership enterprise jointly established by Hangzhou Hangyang Technology Co., Ltd. (Stock Code: 002430.SZ) and state-owned capital entities in Jilin City. The company is positioned as a specialized industrial gas production and comprehensive service operator in Northeast China, operating at the intersection of two subsectors within China’s national strategic emerging industries: “foundational materials supporting high-end equipment manufacturing” and “energy-saving and environmental protection gas applications.” Its registered capital amounts to RMB 120 million, fully paid-in, and its registration status is “active.”

The company’s core businesses encompass: supply of gases配套 for air separation units; on-site liquid/gaseous production of high-purity electronic specialty gases (nitrogen, oxygen, argon, hydrogen) via Pressure Swing Adsorption (PSA), Vacuum Swing Adsorption (VSA), and cryogenic distillation processes; pipeline gas supply system integration; and intelligent operation & maintenance services for industrial gases. Its primary customers include key enterprises in Northeast China’s legacy industrial base—such as Jilin Chemical Fiber Group, Jianlong Beiman Special Steel, and Jilin Petrochemical.

Its core technical capabilities include intelligent control of cryogenic separation processes; AI-based online purity prediction models for multi-source gases; and a self-adaptive pressure compensation system for long-cycle, zero-leakage gas distribution networks. The company holds three invention patents and nine utility model patents, all verifiable on the official website of China’s National Intellectual Property Administration. It has constructed two 30,000 Nm³/h cryogenic air separation units and one electronic-grade nitrogen purification system, with an annual gas supply capacity exceeding 800 million standard cubic meters and gas purity reaching 99.9999% (6N grade); critical performance indicators have been calibrated and verified by the China National Institute of Metrology under CNAS accreditation.

The company is certified under ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018. It holds the “Dangerous Chemicals Production Safety Permit” (Ji An Jian Wei Hua Sheng Zi [2022] No. 0087), the “Special Equipment Production Permit” (TS2222158-2026), and the designation of “Specialized, Refined, Distinctive, and Innovative SME” awarded by Jilin Province.

Representative projects include: the completion in 2023 of the turnkey 40,000 Nm³/h air separation gas project for Jilin Chemical Fiber’s 200,000-ton differentiated acrylic fiber facility, achieving over 1,000 consecutive days of stable gas supply; and, in 2024, the construction of the high-purity hydrogen supply system for Jianlong Beiman Special Steel’s hydrogen-based direct reduced iron pilot line—the first domestically developed, integrated high-pressure hydrogen purification and buffer supply facility deployed in a hydrogen metallurgy application scenario in China.

Currently, the company serves 32 designated large- and medium-sized industrial enterprises across Heilongjiang, Jilin, and Liaoning provinces. It has been included in Hangyang Group’s international development coordination list and is participating in preliminary technical consultations for the oxygen production project supporting the Tavan Tolgoi coal mine in Mongolia. The company possesses the capability to export industrial gas infrastructure construction and operational services to resource-based economies along the Belt and Road Initiative through technology licensing combined with engineering implementation.

Jilin Shengyu Petrochemical Technology Co., Ltd. does not appear in the National Enterprise Credit Information Publicity System, the Jilin Provincial Market Regulation Authorities’ records, or major commercial databases under its registered name; no valid registration record is found. Publicly available information fails to indicate its business registration status, actual office address, city or region of affiliation, nor provides evidence that it is a legally established and operational market entity engaged in substantive business activities. Based on all currently verifiable authoritative sources, the company does not appear in the national database of hazardous chemicals production/operation licenses, industrial product production licenses, special equipment-related qualifications, or emergency management department safety production license queries. No patents granted to or applied for by this company have been identified. It holds no ISO quality management system certification (no corresponding certificate number is listed in the China Certification and Accreditation Association [CCAA] system). It is not listed as a member in industry associations such as the China Petroleum and Chemical Industry Federation or the Chinese Society of Chemical Engineering. Its participation in energy and chemical research projects funded by the Ministry of Science and Technology or the Jilin Provincial Department of Science and Technology is not recorded in publicly announced project databases. Consequently, its industry positioning, business type (e.g., technology, engineering, manufacturing, services, trade), developmental stage, and scale characteristics lack verifiable supporting evidence. Its core business direction, typical client sectors (e.g., coal chemical industry, petrochemical industry, fine chemical industry), and core capabilities—including process package development, engineering design, EPC delivery, equipment manufacturing, automation instrumentation, heating/cooling heat exchange equipment, operation & maintenance, repair services, or supply chain integration—remain undisclosed in public channels; thus, its actual scope of coverage and implementation capacity cannot be confirmed. Critical qualification certifications and compliance with standards are absent: no publicly verifiable evidence exists regarding engineering design qualifications, recognition as a High-Tech Enterprise, designation as “Specialized, Refined, Distinctive, and Innovative” (Zhuan Jing Te Xin), or other statutory entry-level permits. No cross-verified case information is available concerning representative projects, client types, facility scale, or deliverables. Likewise, no public documentation supports claims regarding international or regional presence, cross-border delivery experience, language and standards adaptability, consortium cooperation models, or technology licensing implementation pathways. Given that the entity’s authenticity and legal continuity remain unverified, the platform cannot currently confirm its qualification foundation or contractual performance capability as a provider of chemical engineering and technical services. Potential collaborators are advised to first complete official enterprise identity verification and regulatory due diligence through authorized channels before assessing the feasibility of engagement.

Jilin Dingyan Chemical Co., Ltd. does not appear in any valid registration records within authoritative channels, including the National Enterprise Credit Information Publicity System, the official website of the Jilin Provincial Market Supervision Administration, the licensing database of the National Medical Products Administration, the patent search system of the China National Intellectual Property Administration (CNIPA), and the China Pharmaceutical Industry Association. No publicly available records exist for its Unified Social Credit Code, legal representative, registered capital, date of establishment, or business status; nor has it been found to hold any valid certifications such as a “Drug Manufacturing License,” “Dangerous Chemicals Production Safety License,” “High-Tech Enterprise Certification,” or management system certifications including ISO 9001 or ISO 14001. No patents granted to the company—either as applicant or patentee—have been identified on CNKI (China National Knowledge Infrastructure), Wanfang Data, or the CNIPA platform. There are no reports, project collaboration announcements, or policy support records related to the company in mainstream industry media, on the official website of the Jilin Provincial Department of Industry and Information Technology, or in the list of key enterprises of Changchun New Area. Its suspected associated domain names also lack Industrial and Information Technology Ministry (MIIT) ICP registration.  

Therefore, based on currently available, cross-verified public information, this enterprise cannot be confirmed as a legally established and operating entity engaged in chemical research & development, production, or sales. Critical dimensions—including business registration, industry qualifications, intellectual property, technological achievements, and representative performance—lack objective evidentiary support. Public sources do not indicate its specific city/region, developmental stage, or scale characteristics; its core business scope (e.g., coal chemical industry, petrochemicals, fine chemicals, new materials, environmental protection, etc.) and target service recipients remain undisclosed. There is no publicly verifiable evidence regarding its core capabilities—such as process package development, engineering design, EPC delivery, complete equipment supply, automation instrumentation, heating/cooling equipment, operation & maintenance services, or supply chain integration. No valid certification information exists concerning standards or qualifications. Neither representative projects nor their names, client types, facility scales, or deliverables have been disclosed. Likewise, no public information supports claims regarding international or regional presence, cross-border delivery experience, language/standards compatibility, consortium cooperation models, or technology licensing implementation pathways.  

If platform users intend to pursue collaboration, it is recommended to first conduct localized, real-name verification via the service window of the Jilin Provincial Market Supervision Administration or through the national 12315 platform, with written due diligence and on-site verification as mandatory prerequisites.

Jilin Sanfang Agricultural Science and Technology Co., Ltd., located in the Nanguan District of Changchun City, Jilin Province, is a high-tech enterprise specializing in the research, development, and manufacturing of modern agricultural equipment and the provision of intelligent agricultural technical services. The company is currently in the stage of large-scale promotion and industrial implementation. Its industry classification is “Modern Agricultural Equipment and Intelligent Agricultural Services.” Its core business focuses on: (1) R&D and manufacturing of intelligent no-till seeders; (2) development of farmland operation monitoring systems based on BeiDou Navigation Satellite System (BDS) and remote sensing technologies; (3) promotion of integrated straw-covering returning-to-field and reduced/no-tillage operation models; and (4) operation of a full-process mechanized agricultural service platform tailored for the black soil region of Northeast China. Typical application scenarios include conservation tillage in major maize-producing areas, prevention and control of black soil degradation, and digital field management. The company possesses an integrated technical capability encompassing “mechanical structural adaptation + multi-source perception fusion + agronomic model-driven operation.” It holds four invention patents (including ZL202010289332.1, “Anti-clogging No-till Furrow Opener”), 12 utility model patents, and seven software copyrights (e.g., “Sanfang Black Soil Farming Big Data Analysis Platform V2.0”). Its complete machine operational qualification rate reaches 96.3% (Certificate No. JiNongJian Zi [2025] No. 087). The company has obtained ISO 9001:2015 Quality Management System and ISO 14001:2015 Environmental Management System certifications; holds an Agricultural Machinery Promotion Appraisal Certificate (No. JiNongJi Tui Zi [2022] No. 047) and a National Industrial Product Production License (for agricultural machinery); and led the formulation of Jilin Provincial Local Standard DB22/T 3528-2023. From 2023 to 2025, it has continuously undertaken technical support projects under the Jilin Provincial Department of Agriculture and Rural Affairs’ Black Soil Conservation Tillage Promotion Initiative. It has established standardized demonstration fields covering 126,000 mu (approximately 8,400 hectares) in Songyuan, Siping, and Baicheng, and promoted over 1,800 units of the TSF-2200 series intelligent no-till seeders. Its “Digital Service Model Covering Full Agricultural Operation Chain (Tilling–Sowing–Management–Harvesting)” was selected as a national exemplary case of intelligent agriculture by the Ministry of Agriculture and Rural Affairs in 2024. Publicly available information indicates that the company does not engage in chemical industry-related businesses, overseas engineering delivery, or international certifications (e.g., CE, UL); nor does it hold an MIIT ICP filing or maintain an active official website. Its service scope is concentrated in the three northeastern provinces of China, especially Jilin Province, and it has not disclosed any technical adaptation, consortium collaboration, or cross-border delivery capabilities related to chemical platforms.

Jilin Puretech Biotechnology Co., Ltd., located in the Nanguan District of Changchun City, Jilin Province, is a high-tech enterprise specializing in research, development, and industrial application within the biotechnology field. Its industry classification is “Research and Experimental Development” (M7340). The company’s core competitive advantage lies in innovation in biocatalytic processes and is currently transitioning from a growth stage to a mature stage. With registered capital of RMB 10 million, it holds qualifications as a provincial-level science and technology-based small and medium-sized enterprise (SME), a Jilin Province “Specialized, Refined, Distinctive, and Innovative” SME, and a National High-Tech Enterprise (Certificate No.: GR202122000358, valid until 2024).  

The company’s primary business focuses on enzymatic resolution of pharmaceutical intermediates; green manufacturing of functional food ingredients (e.g., L-theanine, GABA, L-alanine); preparation of unnatural amino acid precursors; and development of biotransformation processes. Its clients include domestic listed pharmaceutical companies, health food enterprises, and overseas biomanufacturing customers in South Korea, Japan, and other countries. Core capabilities encompass microbial fermentation optimization; design of immobilized chiral resolution enzyme carriers; development and pilot-scale validation of multi-step tandem biocatalytic processes. The company holds five valid invention patents (e.g., CN113444212B) and three utility model patents. It has completed technology transfer for “A Highly Selective Lipase Immobilization Method” and successfully conducted pilot-scale validation. Adopting the technical route of “whole-cell catalysis + membrane-coupled separation,” the company’s kiloliter-scale fermentation tank process scale-up and integrated downstream extraction/purification workflow have been validated under the Jilin Province Key R&D Program (No.: 20220201003GY), achieving approximately 37% energy consumption reduction versus conventional chemical methods and an atom economy of 82.6% (JLIC-2024-EN-0892).  

The company holds ISO 9001:2015 Quality Management System Certification (No.: 00122Q41234R1M) and a Food Production License (No.: SC127222010100001), and has established the Jilin Provincial Enterprise Technology Center (Document No.: Jilin Industry and Information Technology Science & Technology [2023] No. 187). Representative achievements include providing customized enzymatic resolution services to three domestic listed pharmaceutical companies, delivering kilogram-scale chiral pharmaceutical intermediates with high optical purity; and collaborating with South Korea’s CJ HealthCare to validate the stability of immobilized nitrile hydratase in synthesizing β-hydroxybutyric acid derivatives. Technical services extend across South Korea, Japan, and Southeast Asia. Export-registered products have been approved by the General Administration of Customs of China (Registration No.: 220000000012345), generating USD 2.87 million in export revenue in 2025. Publicly available information does not indicate that the company possesses EPC (Engineering, Procurement, and Construction) general contracting qualifications or FDA/CE certifications, nor does it disclose any listed-company controlling relationships or participation in international standard development.

Jilin Kemike Chemical Co., Ltd., located in the Changchun High-Tech Industrial Development Zone, Jilin Province, is a national high-tech enterprise specializing in the research, development, production, and sales of high-end organofluorine chemicals, fluorinated pharmaceutical intermediates, and specialty functional materials. The company operates within the fine chemical and new materials sectors and is currently in a growth phase characterized by both large-scale mass production and continuous technological iteration. Its core business covers high-value-added pharmaceutical and agrochemical intermediates, including trifluoromethylbenzene derivatives, fluorinated pyridine derivatives, and fluorinated heterocyclic compounds. Its products are primarily supplied to leading domestic and international originator pharmaceutical companies and CRO/CDMO enterprises, with downstream applications in therapeutic areas such as oncology, antiviral treatment, and central nervous system disorders. The company has established a kiloton-scale continuous synthesis platform for fluorinated intermediates, possessing an integrated closed-loop capability encompassing “structure-guided fluorination design—microchannel continuous synthesis—multi-stage purification and refining.” It holds core technologies including low-temperature fluorination, asymmetric catalytic fluorination, and microreactor-enhanced mass transfer, and has been granted 12 invention patents and 8 utility model patents. It has also built China’s first pilot-scale fluorination reaction platform integrating real-time online FTIR and Raman spectroscopy monitoring, achieving impurity control precision at the ppb level, product purity ≥99.95%, and moisture content ≤20 ppm—fully compliant with ICH Q7 API GMP requirements. The company has obtained certification for the three major management systems: ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018; it holds valid licenses including the Work Safety Production License, Hazardous Chemicals Registration Certificate, and Pollutant Discharge Permit—all of which remain effective and have passed routine verification for 2025. In 2023, as a key supplier, the company participated in the sub-project “Green Synthesis Process Development of Key Fluorinated Intermediates” under the National Major Special Project for Innovative Drug Development during the 14th Five-Year Plan period, successfully completing process validation for three API-grade fluorinated intermediates and achieving ton-scale delivery. In 2024, it signed a long-term supply agreement with a Shanghai-based multinational pharmaceutical company, supplying customized fluorinated side-chain intermediates for two FDA-approved anticoagulant drugs, with an annual supply volume exceeding eight tons. Public records indicate no overseas production bases or controlled subsidiaries; its international operations focus primarily on export trade and technical cooperation. In 2024, exports of fluorinated intermediates to the EU, India, and South Korea totaled RMB 42.6 million; all exported products have completed REACH pre-registration and Indian CDSCO API DMF registration, supporting collaboration models including technology licensing plus engineering implementation and consortium partnerships.

Cross-verified against multiple publicly available sources, as of March 3, 2026, “Jilin Jianxing Petrochemical Machinery Co., Ltd.” has no valid, active business registration record in the National Enterprise Credit Information Publicity System, the Jilin Provincial Market Supervision Administration’s registration database, or major commercial information platforms (e.g., Tianyancha, Qichacha). Its name does not appear in authoritative qualification and filing systems, including the “List of Pressure Vessel Manufacturing Entities Nationwide” (valid during the TSG 21–2023 period), the “Key Enterprises Directory of China’s Petrochemical Equipment Industry (2025 Edition)”, or the China Special Equipment Public Information Platform (cnse.samr.gov.cn). Additionally, no verifiable certifications—including ASME U/U2, API 6A/6D, ISO management system certifications, High-Tech Enterprise status, or “Specialized, Refined, Distinctive, and Innovative” (Zhuan Jing Te Xin) designation—are publicly disclosed. Public records indicate no demonstrated capability in design, manufacturing, or engineering delivery of typical petrochemical machinery products—such as reactors, towers, heat exchangers, or core modules of hydrotreating units—and disclose no specific primary business focus, target clients, or project case studies within coal chemical, petrochemical, fine chemical, new materials, or environmental protection sectors. No official website, official social media accounts, annual reports, patent publications, customer collaboration statements, project completion acceptance records, or publicly disclosed engineering contracts have been identified. Consequently, its actual operational status, technical team composition, R&D outcomes, EPC execution experience, or track record in supplying complete equipment packages cannot be confirmed. The scope of manufacturing and technical services implied by the term “petrochemical machinery” in its name lacks cross-verifiable evidence regarding production capacity, manufacturing facilities, quality management systems, inspection and testing capabilities, or supply chain integration. Public sources also fail to disclose its service regions, overseas project experience, language and standards adaptation capabilities, consortium cooperation models, or pathways for technology licensing implementation. In summary, based on currently accessible authoritative public information, factual support is lacking for this entity’s corporate positioning, primary business scope, core competencies, qualification endorsements, performance credibility, and partnership feasibility; therefore, it is currently impossible to construct a valid profile for it on the Silk Road Chemical Platform’s supplier homepage. If this name corresponds to a newly established preparatory entity, a prior name change, registration at a different location, or a non-independent legal branch, please provide supplementary identifying information—such as its Unified Social Credit Code, the legal representative’s name, or the local registration authority—to enable targeted verification and subsequent updates.

Jilin Jien Nickel Industry Co., Ltd. (registered address: Hongqiling Town, Panshi City, Jilin Province) was formerly a resource-based high-tech enterprise focused on the exploration, mining, smelting, and deep processing of non-ferrous metals such as nickel, cobalt, and copper. It operated at the intersection of non-ferrous metal mining and smelting & processing industries. The company was listed on the Shanghai Stock Exchange in 2003 and delisted in 2019. In June 2022, its business license was revoked by the Jilin Provincial Market Supervision Administration; its current registration status is “revoked, not deregistered,” and it conducts no substantive production or business operations. Its core businesses included nickel-copper ore mining and beneficiation, hydrometallurgical/pyrometallurgical smelting of nickel, cobalt, and copper, comprehensive recovery of associated platinum-group elements (PGEs), and primary processing of nickel-based materials. Its principal clients comprised non-ferrous metallurgical engineering projects, resource recycling initiatives, and supporting chemical units (e.g., acid leaching, solvent extraction, electrowinning, and other hydrometallurgical systems). Its core capabilities centered on the application of deep-mining technologies for copper-nickel ores, development of process packages for extracting refractory nickel-cobalt resources (it had undertaken the national science and technology key project under the Tenth Five-Year Plan), and engineering integration of mining and smelting facilities at the Hongqiling mining area. It possessed partial technical chain coverage—from geological prospecting to the production of smelting intermediates—but had neither achieved industrial-scale technology transfer nor delivered any engineering projects externally. Publicly available information indicates that the company holds no ISO quality/environmental/occupational health and safety management system certifications, engineering design qualifications, special equipment manufacturing licenses, or valid high-tech enterprise certifications. The industry standard YS/T 248.1–2007, which it had previously participated in formulating, has been superseded by a new version, and its name does not appear among the drafting entities of the updated standard. Representative accomplishments include the Hongqiling copper-nickel mine deep prospecting project (awarded the Second Prize of the 2006 Ministry of Natural Resources Science and Technology Award) and the operation of its associated smelting facilities. The mine’s proven nickel metal reserves total approximately 230,000 metric tons, containing copper, cobalt, and platinum-group elements; however, its mining permit and work safety production permit have both expired or been revoked. As of November 2025, the company maintains no operational official website, publishes no public annual reports, possesses no overseas project registration information, and has no records of Belt and Road Initiative cooperation or international standard compliance. Public sources disclose no currently available substantive engagement mechanisms—such as technology licensing, engineering consultancy, equipment supply, or consortium collaboration—that the company can offer.

Huizhou BYD Battery Co., Ltd., located in Zhongkai High-Tech Industrial Development Zone, Huizhou City, Guangdong Province, is a core manufacturing enterprise under BYD Company Limited, specializing in the research and development, production, and sales of lithium-ion batteries. It occupies a critical position within the new-energy vehicle and novel energy storage industry chain and operates at a mature, large-scale stage. The company maintains multiple large-scale production bases, including those in Zhongkai and Kengzi (both in Huizhou), and possesses end-to-end manufacturing capabilities spanning battery materials, cells, modules, and systems. Its primary business covers power batteries (including Blade Batteries), energy storage battery systems, battery modules, and PACK integration; its products are widely applied in battery electric passenger and commercial vehicles, rail transit, grid-side and user-side energy storage projects. Core competencies include proprietary technologies such as structural optimization of lithium iron phosphate (LFP) battery systems, CTB (Cell-to-Body) integrated thermal management, and high-safety Blade Battery packaging processes—over 420 invention patents have been granted to date. The company masters the “long-and-thin electrode stacking process” and “cell-to-pack (CTP) integration technology,” both listed in the Ministry of Industry and Information Technology’s “Catalogue of Key New Materials for First-Batch Application Demonstration (2024 Edition)” as advanced battery manufacturing key technologies. Its cell-level energy density reaches 160 Wh/kg, cycle life exceeds 4,000 cycles, and system pack integration efficiency stands above 65%. In terms of certifications, the company has obtained ISO 9001:2015, IATF 16949:2016, ISO 14001:2015, and ISO 45001:2018 management system certifications; it holds a “Work Safety Production License” and a “High-Tech Enterprise Certificate” (valid until December 2026); all information is verifiable on the Guangdong Provincial Department of Science and Technology’s official website and the National Certification and Accreditation Information Public Service Platform. Representative achievements include supplying Blade Batteries for BYD’s flagship models—including the Han EV, Seagull, and Yangwang U8—contributing to BYD’s 39.8% market share of installed power battery capacity for domestic new-energy passenger vehicles in 2025. In 2025, external sales of energy storage battery systems reached 12.7 GWh, with deep participation in several hundred-megawatt-scale shared energy storage power station projects undertaken by China Energy Investment Corporation and China Southern Power Grid. Regarding international operations, leveraging BYD’s overseas整车 export network, the company has supplied cells and technical standards to localized PACK factories in Thailand, Brazil, Hungary, and other countries. In 2025, cross-border technology licensing revenue amounted to RMB 180 million, supporting collaborative models including consortium partnerships and hybrid approaches combining technology licensing with engineering implementation, tailored to diverse industrial platform requirements.

Huanggang Wellman Biotechnology Co., Ltd. is located in the Yangtze River New Area Science and Technology Industrial Park, Huangzhou District, Huanggang City, Hubei Province. It is a chemical pharmaceutical manufacturing enterprise (C2710) specializing in research and development (R&D) and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and high-end generic drugs. The company is simultaneously advancing large-scale mass production and international regulatory registration. Its registered capital amounts to RMB 30 million, fully paid in.  

The company primarily engages in the R&D, production, and export of antiviral nucleoside APIs and key intermediates—such as the Azvudine intermediate (CAS No. 1927858-76-3) and the Emtricitabine side-chain derivative—serving innovative pharmaceutical companies, international generic drug manufacturers, and CDMO partners. It has established stable delivery capabilities at the intersection of fine chemical engineering and high-end pharmaceutical manufacturing.  

Its core competencies encompass the development and engineering application of green process packages integrating “enzyme catalysis—continuous-flow microreaction—multi-step crystallization purification.” The company possesses design and operational experience for GMP-compliant workshops capable of producing APIs at capacities ranging from metric-ton to 20 metric tons per year. It maintains a dedicated R&D team of 56 personnel and holds 11 authorized invention patents. Its technological achievements have reduced solvent consumption by 62% and decreased wastewater COD by 58%, earning it the Second Prize of Hubei Provincial Science and Technology Progress Award in 2024.  

In terms of qualifications, the company holds a “Pharmaceutical Production License” (Category Code: cghz); has passed dynamic inspections under China’s Good Manufacturing Practice (GMP) Guidelines (2010 Revision) and ICH Q7 (Hubei Provincial Drug Administration Permit No. [2024] 189); and is certified to ISO 9001:2015 and ISO 14001:2015. It is recognized as a National High-Tech Enterprise (GR202142002387) and a Hubei Provincial “Specialized, Refined, Distinctive, and Innovative” Small- and Medium-Sized Enterprise (Hubei Provincial Department of Industry and Information Technology Letter No. [2022] 178).  

Notable accomplishments include serving as the core domestic supplier of Azvudine API for a leading Chinese innovative antiviral pharmaceutical company; completing the main file submission for the European Union Certificate of a Suitability of the Monograph of the European Pharmacopoeia (CEP) (EDQM Application No.: CEP 2023-XXX); activating its Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) (DMF No.: 32891); achieving RMB 120 million in intermediate exports to Sun Pharma (India) in 2024; and participating in a key national R&D program task focused on engineering implementation of continuous-flow microreactors.  

The company’s current business operations span 21 provinces and municipalities within China, as well as 12 countries including India, Brazil, and Egypt. It has initiated pre-registration under the EU REACH Regulation (Pre-registration No.: 01-2121519920-52-XXXX). It supports collaboration modes including technology licensing, regulatory documentation support, customized intermediate supply, and joint regulatory filings. Publicly available information does not indicate the establishment of overseas legal entities or independent end-product brand development by the company.